INDIANAPOLIS (WISH) — The state of Indiana will receive an estimated $16.5 million as part of a $720 million national opioid settlement, Attorney General Todd Rokita announced Monday.
The settlement involved eight drugmakers that manufactured opioid pills. The defendants are Alvogen; Amneal; Apotex; Hikma; Indivior; Mylan (now part of Viatris); Sun; and Zydus.
“Thousands of Hoosiers have lost their lives as a result of the opioid crisis,” Rokita said in a release Monday. “We can never undo that tragic loss of life, but we can hold accountable those responsible for contributing to the situations culminating in these deaths. That’s what these settlements are all about, and I’m proud of the work of our team.”
All eight drug makers are banned from promoting opioids or opioid products. They cannot manufacture, promote or distribute any product containing over 40 mg of oxycodone per pill and are not allowed to offer discounts, coupons, or rebates for opioid products.
Some of the companies will make payments to states annually, while others will pay their obligation in a single year, Rokita says.
This settlement brings Indiana to approximately $1.1 billion the total value of opioid settlements achieved since Rokita took office in January of 2021.
About The Author
You may also like
-
Former Warren Central star JuJu Brents healthy, ready for Year 3 with Colts
-
Indianapolis program aims to house homeless people, but not ones in Fountain Square
-
NYPD officer among 5 killed in a Manhattan high-rise shooting; gunman dead
-
Health Spotlight | Research eyes how food can act as medicine
-
Indianapolis man charged with criminal recklessness in July 5 shooting